` 539428 (Tejnaksh Healthcare Ltd) vs BSE Sensex 30 Comparison - Alpha Spread

539428
vs
B
BSE Sensex 30

Over the past 12 months, TEJNAKSH has underperformed BSE Sensex 30, delivering a return of -49% compared to the BSE Sensex 30's 5% drop.

Stocks Performance
539428 vs BSE Sensex 30

Loading
539428
BSE Sensex 30
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
539428 vs BSE Sensex 30

Loading
539428
BSE Sensex 30
Difference
www.alphaspread.com

Performance By Year
539428 vs BSE Sensex 30

Loading
539428
BSE Sensex 30
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Tejnaksh Healthcare Ltd vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Tejnaksh Healthcare Ltd
Glance View

Market Cap
227.1m INR
Industry
Health Care

Tejnaksh Healthcare Ltd. engages in the provision of hospital services. The company is headquartered in Mumbai, Maharashtra. The company went IPO on 2015-10-27. The firm is engaged in the provision of hospital and healthcare service in Mumbai and other parts of Maharashtra. The firm offers healthcare services at 13 urology clinics, four urology hospitals and two dental super specialty clinics. The firm's domains include urology hospitals, nephrology hospitals, dental clinics, pathology labs, research and development, healthcare equipment, super specialty training institutes, education institutes, simulation institute and stone analysis lab.

TEJNAKSH Intrinsic Value
17.8 INR
Undervaluation 37%
Intrinsic Value
Price
Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett